Hjem › Medulloblastom › New Jersey
Kliniske studier for Medulloblastom i New Jersey
3 studier for Medulloblastom søker deltakere på steder i New Jersey.
Offisiell studietekst (engelsk)
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Saint Peter's University Hospital, New Brunswick
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick
- Newark Beth Israel Medical Center, Newark
- og 1 flere
RekruttererFase 3
Alder 4 til 21 · Alle kjønn · Oppdatert 25. aug. 2026 · NCT05382338DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Hackensack University Medical Center, Hackensack
RekruttererFase 2
Opp til 21 år · Alle kjønn · Oppdatert 12. aug. 2026 · NCT04696029A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
- Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale
RekruttererFase 1
Alder 3 til 22 · Alle kjønn · Oppdatert 13. jul. 2026 · NCT07698899Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.